Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 378 Million | 345.29 Million | 934.21 Million | 366.65 Million | 362.71 Million | 214.29 Million |
| Net Income | 103.39 Million | -438.32 Million | 230.79 Million | 211.33 Million | 132.41 Million | -684.48 Million |
| Depreciation & Amortization | 229.27 Million | 181.47 Million | 149.94 Million | 140.89 Million | 152.6 Million | 179.32 Million |
| Deferred income taxes | -5.18 Million | -23.61 Million | 6.77 Million | 4.19 Million | -2.8 Million | -163.55 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -70.76 Million | -100.27 Million | 298.07 Million | -243.73 Million | -45.13 Million | -518.1 Million |
| Other non-cash items | 650.58 Million | 702.42 Million | 255.4 Million | 258.15 Million | 122.82 Million | 1.23 Billion |
| Investing Cash Flow | -115.98 Million | -307.77 Million | -687.66 Million | -427.77 Million | 548.43 Million | -356.66 Million |
| Investments in PPE | -130.38 Million | -322.92 Million | -447.77 Million | -395.73 Million | -201.27 Million | -321.32 Million |
| Acquisitions | 92.24 Thousand | 70.77 Million | -332.03 Million | -61.97 Thousand | 593.6 Million | 3.24 Million |
| Investment purchases | -50 Million | -20 Million | 6.63 Million | -100 Million | 11 Million | -115 Million |
| Sales/Maturities of investments | 50 Million | 369.92 Thousand | 104.07 Million | 1.44 Million | 1.55 Million | 1.02 Million |
| Other Investing Activities | 14.3 Million | -35.99 Million | -18.56 Million | 66.57 Million | 143.54 Million | 75.39 Million |
| Financing Cash Flow | -151.69 Million | 168.86 Million | -485.01 Million | -703.01 Million | -333.95 Million | -553.28 Million |
| Debt repayment | -106.68 Million | -735.4 Million | -1.38 Billion | -1.07 Billion | -1.07 Billion | -1.29 Billion |
| Dividends payments | -41.17 Million | -49.11 Million | -102.95 Million | -475.15 Million | -65.5 Million | -129.52 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -33.9 Million | 953.38 Million | 1.05 Billion | 917.48 Million | 807.16 Million | 873 Million |
| Accounts receivables | 44.61 Million | 69.38 Million | 241.24 Million | -185.85 Million | 8.14 Million | -363.5 Million |
| Accounts payables | -88.77 Million | -57.63 Million | 137.13 Million | 9.81 Million | -29.3 Million | 35.4 Million |
| Inventory | -26.6 Million | -88.4 Million | -87.08 Million | -71.89 Million | -51.6 Million | -26.45 Million |
| Other working capital | -93.95 Million | -23.61 Million | 6.77 Million | 4.19 Million | 27.62 Million | -491.64 Million |
| Cash at beginning of period | 592.35 Million | 378.96 Million | 617.43 Million | 1.38 Billion | 804.37 Million | 1.5 Billion |
| Cash at end of period | 699.46 Million | 585.35 Million | 378.96 Million | 617.43 Million | 1.38 Billion | 804.37 Million |
| Capital Expenditure | -130.38 Million | -322.92 Million | -447.77 Million | -395.73 Million | -201.27 Million | -321.32 Million |
| Effect of forex changes on cash | -3.21 Million | 1.15 | - | 0.28 | 0.51 | - |
| Net cash flow / Change in cash | 107.11 Million | 206.39 Million | -238.46 Million | -764.13 Million | 577.19 Million | -695.65 Million |
| Free Cash Flow | 247.62 Million | 22.37 Million | 486.43 Million | -29.08 Million | 161.43 Million | -107.03 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -62.65 Million | -38.03 Million | -68.45 Million | -66.47 Million | 103.39 Million | 41.96 Million |
| Depreciation & Amortization | - | 56.05 Million | 56.05 Million | 57.2 Million | 229.27 Million | -100.79 Million |
| Deferred income taxes | - | - | - | - | -5.18 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 18 Million | -70.76 Million | 26.69 Million |
| Other non-cash items | 59.36 Million | 201.43 Million | 164.2 Million | 25.71 Million | 650.58 Million | 173.37 Million |
| Investing Cash Flow | -19.56 Million | -26.16 Million | -10.64 Million | -13.15 Million | -115.98 Million | 20.97 Million |
| Investments in PPE | -20.34 Million | -26.17 Million | -22.15 Million | -27.46 Million | -130.38 Million | -29.42 Million |
| Acquisitions | 775 Thousand | 7510.00 | 195 Thousand | 5000.00 | 92.24 Thousand | 15.07 Thousand |
| Investment purchases | 2601.48 | -2601.48 | 1.00 | - | -50 Million | -15.07 Thousand |
| Sales/Maturities of investments | - | 2601.48 | 10.4 Thousand | - | 50 Million | 50.38 Million |
| Other Investing Activities | 775 Thousand | -2601.48 | 11.3 Million | 14.3 Million | 14.3 Million | 15.07 Thousand |
| Financing Cash Flow | -102.47 Million | -114.76 Million | -13.97 Million | -7.55 Million | -151.69 Million | -151.51 Million |
| Debt repayment | -91.72 Million | -25.16 Million | -1.41 Million | -7.63 Million | -106.68 Million | -451.31 Million |
| Dividends payments | -7.99 Million | -61.63 Million | -9.28 Million | -9.48 Million | -41.17 Million | -9.65 Million |
| Common Stock Repurchased | 25 Million | -25 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.75 Million | -58.36 Million | -12.55 Million | -4.08 Million | -33.9 Million | 309.45 Million |
| Accounts receivables | - | - | - | 44.61 Million | 44.61 Million | 22.27 Million |
| Accounts payables | - | - | - | - | -88.77 Million | - |
| Inventory | - | - | - | -26.6 Million | -26.6 Million | 4.41 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 733.22 Million | 770.59 Million | 699.46 Million | 685.49 Million | 592.35 Million | 671.61 Million |
| Cash at end of period | 607.87 Million | 737.22 Million | 770.59 Million | 699.46 Million | 699.46 Million | 683.93 Million |
| Capital Expenditure | -20.34 Million | -26.17 Million | -22.15 Million | -27.46 Million | -130.38 Million | -29.42 Million |
| Effect of forex changes on cash | - | - | - | 230.28 Thousand | -3.21 Million | 1.61 Million |
| Net cash flow / Change in cash | -125.34 Million | -33.37 Million | 71.13 Million | 13.97 Million | 107.11 Million | 12.31 Million |
| Free Cash Flow | -23.63 Million | 81.16 Million | 73.59 Million | 6.99 Million | 247.62 Million | 111.81 Million |
RFK
002069
ERA
YUMAQ
RAJPUTANA
STANCAP